Fatih Kurnaz

Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia

Süleyman Yazar, Ozan Yaman, Bülent Eser et al. · Journal of Medical Microbiology · 2004 · 61 citations

Autoimmune Disease, Parasitic Protozoa, Anti-toxoplasma Gondii Antibodies +11

The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload

Süleyman Baldane, Gülşah Akyol, Muzaffer Keklık et al. · Transfusion and Apheresis Science · 2013 · 35 citations

Transplantation, Marrow Transplantation, Hematology +8

Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation

Süleyman Baldane, Leylagül Kaynar, Fatih Kurnaz et al. · Neoplasma · 2011 · 33 citations · Full text

Iron Metabolism, Solid Organ Transplantation, Transplantation Medicine +19

The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey

Esen Karakuş, Leylagül Kaynar, Fatih Kurnaz et al. · Transfusion and Apheresis Science · 2013 · 30 citations

Regenerative Medicine, Translational Medicine, Cell Therapy +14

Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)

Bülent Eser, Sami Bahçebaşı, Leylagül Kaynar et al. · Annals of Hematology · 2011 · 26 citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +7